Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

This study has been completed.

Study NCT00589823 Information provided by Archimedes Development Ltd

First Received: December 27, 2007 Last Updated: January 20, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2009
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: January 20, 2010